Dr. Nicholas Richard Binder, MD

Dr. Binder practices at Premiere Ambulatory Surgery Center in Escondido, California.

Dr. Binder's NPI, 1306076716, was assigned on July 20, 2009. Dr. Binder graduated from UC Irvine School of Medicine in 2009. Dr. Binder holds California license A124698.

Dr. Binder's primary practice is Premiere Ambulatory Surgery Center, at 700 W El Norte Pkwy, Escondido, CA 92026. The practice phone is (760) 738-7830.

Dr. Binder's primary practice is Premiere Ambulatory Surgery Center in Escondido, California. Dr. Binder is also affiliated with Sharp Grossmont Hospital. The medical group on file is Children's Hospital Los Angeles Medical Group. Dmand AI also links Dr. Binder to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Binder practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Binder's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Binder is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Binder's licenses on file in 3 states: California, Missouri and Illinois.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Binder treats.

CMS data shows 1,616 Medicare services from Dr. Binder across 15 procedure codes in 2024, for 598 Medicare patients. Medicare paid $142,630 for them.

CMS counts 598 Medicare patients who saw Dr. Binder in 2024. The largest group is 65 to 74, with 307 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 68% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Binder's median patient age at 71, with 59% women.

In 2024, Dr. Binder wrote 4,177 Medicare Part D claims for 825 patients. 44% of them were for generic drugs. CMS names the drug for 4,084 of them, across 24 drugs with 11 or more claims each, at $428,957 in total drug cost. In 2023, CMS named 2,762 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Binder for performance year 2024, reported individually. Dr. Binder accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 134 procedures of cataract surgery by Dr. Binder, more than 78% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Binder, published from 2008 to 2024. 2008 was the busiest year, with 2. The most frequent topics are CD4-Positive T-Lymphocytes, Epitopes, T-Lymphocyte and Vaccination. Dr. Binder's most frequent co-authors are Jeffrey Bloom, DO, Winston Douglas Chamberlain, MD, PhD and Tom S. Chang, MD.

CMS Open Payments shows 102 general payments to Dr. Binder from 21 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 99% of the total. Alcon Laboratories Inc paid the most, $1,342.

Dr. Binder graduated from UC Irvine School of Medicine in 2009.

Dr. Binder is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.